Unicycive Therapeutics (UNCY)
Unicycive Therapeutics on one page: short interest, daily short volume, fails to deliver, planned sales, large holders, 13F holders, earnings dates and insider trades. Listed on Nasdaq.
4.9M
Short interest
settlement 2026-09-30
5.7
Days to cover
+1.1 days vs prior
46.2%
Short share of volume
2026-10-23
2,181
Fails to deliver
settlement 2026-09-30
Tue 27 Oct
Next earnings
estimated date
$0
Insider flow, 90 days
0 buys, 0 sells
As of 2026-10-23.
Short interest
FINRA, twice a month. The newest 48 settlements in the table, 48 in the chart. JSONAs of 30 September 2026, short interest in UNCY is 4,854,102 shares, up 943,289 shares over the last month. Over the last 48 readings it ranged from 356,897 shares (30 May 2025) to 4,939,936 shares (15 July 2026). The latest reading sits at the top of that range. At the reported average volume of 846K shares a day that is 5.7 days to cover.
Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/uncy" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-09-30 | 4,854,102 | +15.5% | 846,033 | 5.74 |
| 2026-09-15 | 4,202,801 | +7.5% | 905,197 | 4.64 |
| 2026-08-31 | 3,910,813 | -5.8% | 668,814 | 5.85 |
| 2026-08-14 | 4,153,197 | -4.1% | 761,119 | 5.46 |
| 2026-07-31 | 4,331,038 | -12.3% | 852,336 | 5.08 |
| 2026-07-15 | 4,939,936 | +5.8% | 1,939,698 | 2.55 |
| 2026-06-30 | 4,671,324 | +44.4% | 3,897,959 | 1.20 |
| 2026-06-15 | 3,236,158 | +14.1% | 884,504 | 3.66 |
| 2026-05-29 | 2,837,490 | +39.8% | 752,215 | 3.77 |
| 2026-05-15 | 2,029,225 | -5.7% | 631,086 | 3.22 |
| 2026-04-30 | 2,151,215 | -0.5% | 465,360 | 4.62 |
| 2026-04-15 | 2,161,598 | +18.4% | 635,085 | 3.40 |
| 2026-03-31 | 1,825,494 | +6.1% | 437,869 | 4.17 |
| 2026-03-13 | 1,720,898 | -12.3% | 472,260 | 3.64 |
| 2026-02-27 | 1,961,264 | +7.1% | 410,490 | 4.78 |
| 2026-02-13 | 1,830,680 | +11.9% | 534,206 | 3.43 |
| 2026-01-30 | 1,636,214 | +2.5% | 793,778 | 2.06 |
| 2026-01-15 | 1,595,652 | +2.8% | 527,047 | 3.03 |
| 2025-12-31 | 1,552,662 | +8.3% | 333,061 | 4.66 |
| 2025-12-15 | 1,434,320 | +26.0% | 359,393 | 3.99 |
| 2025-11-28 | 1,138,223 | -8.6% | 369,888 | 3.08 |
| 2025-11-14 | 1,245,067 | +2.9% | 520,145 | 2.39 |
| 2025-10-31 | 1,210,191 | +19.5% | 536,704 | 2.25 |
| 2025-10-15 | 1,012,624 | -13.7% | 319,207 | 3.17 |
| 2025-09-30 | 1,172,878 | -22.2% | 499,023 | 2.35 |
| 2025-09-15 | 1,507,501 | +17.5% | 455,305 | 3.31 |
| 2025-08-29 | 1,282,752 | +4.8% | 587,317 | 2.18 |
| 2025-08-15 | 1,223,492 | -13.8% | 361,810 | 3.38 |
| 2025-07-31 | 1,419,748 | -0.1% | 431,127 | 3.29 |
| 2025-07-15 | 1,420,615 | +78.3% | 824,400 | 1.72 |
| 2025-06-30 | 796,858 | -78.4% | 1,633,943 | 1.00 |
| 2025-06-13 | 3,692,820 | +934.7% | 11,806,190 | 1.00 |
| 2025-05-30 | 356,897 | -46.4% | 970,886 | 1.00 |
| 2025-05-15 | 666,099 | -16.0% | 763,923 | 1.00 |
| 2025-04-30 | 793,044 | -24.0% | 440,660 | 1.80 |
| 2025-04-15 | 1,042,922 | -39.1% | 1,496,722 | 1.00 |
| 2025-03-31 | 1,713,889 | +12.5% | 992,532 | 1.73 |
| 2025-03-14 | 1,523,377 | +8.9% | 594,844 | 2.56 |
| 2025-02-28 | 1,399,359 | +76.0% | 992,315 | 1.41 |
| 2025-02-14 | 795,150 | -3.4% | 937,099 | 1.00 |
| 2025-01-31 | 823,318 | -51.5% | 881,374 | 1.00 |
| 2025-01-15 | 1,696,860 | +37.4% | 1,460,308 | 1.16 |
| 2024-12-31 | 1,235,170 | +24.9% | 1,235,216 | 1.00 |
| 2024-12-13 | 989,174 | +18.1% | 1,409,313 | 1.00 |
| 2024-11-29 | 837,234 | -33.8% | 1,444,306 | 1.00 |
| 2024-11-15 | 1,263,934 | +19.9% | 2,166,261 | 1.00 |
| 2024-10-31 | 1,054,147 | +0.9% | 1,549,346 | 1.00 |
| 2024-10-15 | 1,045,124 | +5.2% | 1,302,467 | 1.00 |
Daily short volume
FINRA Reg SHO, the last 30 sessions. JSONAs of 23 October 2026, the short share of UNCY volume is 46.2%, down 12.0 points over the last five sessions. Over the last 30 readings it ranged from 37.8% (15 October 2026) to 74.1% (19 October 2026). The latest reading is 9.7 points below the 30-session average of 55.9%, on 701K shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-10-23 | 324K | 701K | 46.2% | 12,310 |
| 2026-10-22 | 152K | 368K | 41.4% | 0 |
| 2026-10-21 | 287K | 564K | 51.0% | 1,505 |
| 2026-10-20 | 285K | 571K | 50.0% | 0 |
| 2026-10-19 | 367K | 494K | 74.1% | 0 |
| 2026-10-16 | 321K | 551K | 58.2% | 10,232 |
| 2026-10-15 | 175K | 464K | 37.8% | 3,488 |
| 2026-10-14 | 291K | 485K | 60.0% | 14,188 |
| 2026-10-13 | 557K | 959K | 58.1% | 5,637 |
| 2026-10-12 | 173K | 318K | 54.4% | 9 |
| 2026-10-09 | 101K | 228K | 44.2% | 0 |
| 2026-10-08 | 288K | 526K | 54.8% | 112 |
| 2026-10-07 | 156K | 279K | 55.9% | 97 |
| 2026-10-06 | 211K | 387K | 54.5% | 300 |
| 2026-10-05 | 134K | 258K | 51.8% | 33,701 |
| 2026-10-02 | 418K | 737K | 56.8% | 11,361 |
| 2026-10-01 | 367K | 548K | 67.0% | 3,404 |
| 2026-09-30 | 219K | 355K | 61.8% | 3,497 |
| 2026-09-29 | 634K | 1.2M | 50.9% | 1,011 |
| 2026-09-28 | 104K | 241K | 42.9% | 0 |
| 2026-09-25 | 179K | 270K | 66.3% | 0 |
| 2026-09-24 | 140K | 257K | 54.6% | 700 |
| 2026-09-23 | 249K | 340K | 73.2% | 690 |
| 2026-09-22 | 128K | 238K | 53.7% | 100 |
| 2026-09-21 | 87K | 177K | 49.3% | 1,206 |
| 2026-09-18 | 271K | 431K | 63.0% | 0 |
| 2026-09-17 | 171K | 316K | 54.1% | 0 |
| 2026-09-16 | 291K | 464K | 62.8% | 15 |
| 2026-09-15 | 726K | 993K | 73.0% | 8,062 |
| 2026-09-14 | 165K | 296K | 55.6% | 6,269 |
Fails to deliver
SEC, the last 30 settlement dates with a fail. JSONAs of 30 September 2026, the fails-to-deliver balance in UNCY is 2,181 shares, up 2,178 shares over the last settlement date. Over the last 30 readings it ranged from 3 shares (29 September 2026) to 166,791 shares (1 July 2026). The latest reading sits at the bottom of that range.
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-09-30 | 2,181 | $4.55 | $10K |
| 2026-09-29 | 3 | $4.64 | $14 |
| 2026-09-28 | 109 | $4.70 | $512 |
| 2026-09-22 | 1,153 | $4.77 | $5K |
| 2026-09-11 | 3,635 | $5.31 | $19K |
| 2026-09-10 | 3,301 | $5.12 | $17K |
| 2026-09-01 | 569 | $5.20 | $3K |
| 2026-08-31 | 6,457 | $5.27 | $34K |
| 2026-08-25 | 7,679 | $5.34 | $41K |
| 2026-08-14 | 12,259 | $5.40 | $66K |
| 2026-08-06 | 1,262 | $5.23 | $7K |
| 2026-07-24 | 125 | $5.46 | $683 |
| 2026-07-23 | 23 | $5.57 | $128 |
| 2026-07-20 | 2,266 | $5.38 | $12K |
| 2026-07-17 | 3,978 | $5.05 | $20K |
| 2026-07-10 | 188 | $5.26 | $989 |
| 2026-07-09 | 498 | $5.43 | $3K |
| 2026-07-06 | 10,000 | $5.73 | $57K |
| 2026-07-02 | 692 | $5.28 | $4K |
| 2026-07-01 | 166,791 | $4.69 | $782K |
| 2026-06-30 | 22,531 | $7.70 | $173K |
| 2026-06-29 | 6,923 | $7.13 | $49K |
| 2026-06-17 | 6,322 | $7.17 | $45K |
| 2026-06-15 | 10,068 | $7.25 | $73K |
| 2026-06-11 | 6,381 | $7.69 | $49K |
| 2026-06-10 | 1,472 | $7.27 | $11K |
| 2026-06-09 | 4 | $6.66 | $27 |
| 2026-06-08 | 86,110 | $6.92 | $596K |
| 2026-06-04 | 8,459 | $7.20 | $61K |
| 2026-05-12 | 1,734 | $7.95 | $14K |
Insider trades
SEC Form 4, newest first. JSONNo open-market insider trades were reported for UNCY in the last 90 days. The most recent filings are listed below. Latest filing: Aggarwal Gaurav (Director) on 2025-08-25.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2025-08-25 | Aggarwal Gaurav | Director | Conversion | 653K | price not stated in the filing | not stated | 1.8M |
| 2025-02-18 | Aggarwal Gaurav | Director | Conversion | 1.4M | price not stated in the filing | not stated | 11.4M |
| 2024-10-09 | Aggarwal Gaurav | Director | Conversion | 5.5M | price not stated in the filing | not stated | 10.0M |
| 2023-07-11 | Gupta Shalabh K. | CEO | Exercise or conversion | 105K | price not stated in the filing | not stated | 2.5M |
| 2023-07-11 | Gupta Pramod | EVP, Pharmaceuticals and BD | Exercise or conversion | 42K | price not stated in the filing | not stated | 42K |
| 2023-07-11 | Jermasek Douglas | EVP of Corporate Strategy | Exercise or conversion | 105K | price not stated in the filing | not stated | 175K |
| 2023-07-11 | Aggarwal Gaurav | Director | Conversion | 3.5M | price not stated in the filing | not stated | 3.5M |
| 2022-07-15 | Schiller Brigitte | Director | Exercise or conversion | 27K | $0.00 | $0 | 27K |
| 2022-05-16 | Schiller Brigitte | Director | Buy | 15K | $0.83 | $12K | 15K |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.
Planned sales (Form 144)
Newest first. JSON1 Form 144 notice on file for UNCY worth $9.5M at the prices reported; 0 in the last 90 days worth $0. Latest: Vivo Opportunity Fund Holdings, L.P. filed on 2026-07-01 to sell 1,789,916 shares ($9.5M) from 2026-06-30.
| Filed | Seller | Shares | Market value | Of outstanding | Sale from | Broker |
|---|---|---|---|---|---|---|
| 2026-07-01 | Vivo Opportunity Fund Holdings, L.P.Director | 1.8M | $9.5M | 6.534% | 2026-06-30 | BTIG, LLC |
Large holders (13D and 13G)
One row per reporting person with its latest filing, newest first. JSON10 holders report 5% or more of UNCY in their latest filing, all on Schedule 13G (passive). The largest reported stake is Vivo Opportunity Fund Holdings, L.P. at 10.0% of the class (4,856,259 shares), filed 2026-08-14 for an event on 2026-06-30.
| Filed | Form | Holder | Shares | Of class | Event |
|---|---|---|---|---|---|
| 2026-08-14 | 13G/Ano. 4 | Vivo Opportunity Fund Holdings, L.P.partnership | 4.9M | 10.0% | 2026-06-30 |
| 2026-08-14 | 13G/Ano. 4 | Vivo Opportunity, LLCother entity | 4.9M | 10.0% | 2026-06-30 |
| 2026-08-14 | 13G/Ano. 10 | Wilmot B. Harkeyparent holding company | 2.8M | 10.0% | 2026-06-30 |
| 2026-08-14 | 13G/Ano. 10 | Nantahala Capital Management, LLCinvestment adviser | 2.8M | 10.0% | 2026-06-30 |
| 2026-08-14 | 13G/Ano. 10 | Daniel Mackparent holding company | 2.8M | 10.0% | 2026-06-30 |
| 2026-07-30 | 13G | BlackRock, Inc.parent holding company | 1.4M | 5.3% | 2026-06-30 |
| 2026-07-08 | 13G/Ano. 1 | Israel A. Englanderindividual | 271K | 1.0% | 2026-06-30 |
| 2026-07-08 | 13G/Ano. 1 | Millennium Group Management LLCother entity | 271K | 1.0% | 2026-06-30 |
| 2026-07-08 | 13G/Ano. 1 | Millennium Management LLCother entity | 271K | 1.0% | 2026-06-30 |
| 2026-07-08 | 13G/Ano. 1 | Integrated Core Strategies (US) LLCother entity | 206K | 0.8% | 2026-06-30 |
| 2026-05-15 | 13G/Ano. 7 | Rajeev Shahparent holding company, individual | 2.8M | 9.9% | 2026-03-31 |
| 2026-05-15 | 13G/Ano. 7 | RA Capital Healthcare Fund, L.P.partnership | 2.8M | 9.9% | 2026-03-31 |
| 2026-05-15 | 13G/Ano. 7 | Peter Kolchinskyparent holding company, individual | 2.8M | 9.9% | 2026-03-31 |
| 2026-05-15 | 13G/Ano. 7 | RA Capital Management, L.P.investment adviser, partnership | 2.8M | 9.9% | 2026-03-31 |
| 2026-02-10 | 13G/Ano. 3 | Octagon Capital Advisors LPinvestment adviser, partnership | 1.0M | 4.7% | 2025-12-31 |
| 2026-02-10 | 13G/Ano. 3 | Ting Jiaparent holding company, individual | 1.0M | 4.7% | 2025-12-31 |
| 2026-02-10 | 13G/Ano. 3 | Octagon Investments Master Fund LPpartnership, other entity | 650K | 3.0% | 2025-12-31 |
| 2026-02-10 | 13G/Ano. 3 | Octagon Biotech Opportunities Fund I LPpartnership, other entity | 350K | 1.7% | 2025-12-31 |
| 2025-11-14 | 13G/Ano. 4 | Great Point Partners, LLCinvestment adviser, other entity | 797K | 4.5% | 2025-09-30 |
| 2025-11-14 | 13G/Ano. 4 | Dr. Jeffrey R. Jay, M.D.parent holding company, individual | 797K | 4.5% | 2025-09-30 |
| 2025-11-14 | 13G/Ano. 4 | Ms. Lillian Nordahlparent holding company, individual | 797K | 4.5% | 2025-09-30 |
| 2025-11-14 | 13G/Ano. 2 | Octagon Private Opportunities Fund II LPpartnership, other entity | 350K | 2.0% | 2025-09-30 |
13F holders
Tracked managers holding UNCY at their latest 13F. JSON2 of the 30 tracked managers held UNCY at their latest 13F, $1.6M in total at quarter-end prices. Millennium Management is the largest at $1.3M (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 0 added shares and 2 cut.
| Fund | Quarter | Shares | Value | Of portfolio | Change in shares |
|---|---|---|---|---|---|
| Millennium Management | 2026-06-30 | 271K | $1.3M | 0.00% | -1.1M |
| Citadel Advisors | 2026-06-30 | 61K | $287K | 0.00% | -176K |
Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.
What this page is
Unicycive Therapeutics in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.
This page follows Unicycive Therapeutics (UNCY), SEC CIK 1766140, listed on Nasdaq. The cross-market tables live on the short interest and insider transactions hubs.
Source and updates
- Short interest
- FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-09-30.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-10-23.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-09-30.JSON and CSV
- Planned sales
- SEC EDGAR Form 144Source: SEC.New notices appear shortly after the SEC posts them; a notice is filed on or before the sale. Latest 2026-07-01.JSON and CSV
- Large holders
- SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-08-14.JSON and CSV
- 13F holders
- SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
- Earnings dates
- SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2025-10-28.JSON and CSV
- Insider trades
- SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2025-08-25.JSON and CSV
- Company record
- EDGAR filing index for CIK 1766140Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 10 requests a minute without a key, 30 with a free key from a free account.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other company pages
- MLMMartin Marietta Materials
- MMM3M
- MNSTMonster Beverage
- MOAltria Group
- MODModine Manufacturing
- MOSMosaic
- MPMP Materials
- MPCMarathon Petroleum
- MPWRMonolithic Power Systems
- MRKMerck
- MRNAModerna
- MRSHMarsh & McLennan Companies
- MRVLMarvell Technology
- MSMorgan Stanley
- MSCIMSCI
- MSFTMicrosoft
- MSIMotorola Solutions
- MSTRStrategy
- MTBM&T Bank
- MTCHMatch Group
- MTDMettler-Toledo International
- MTNVail Resorts
- MTSIMACOM Technology Solutions Holdings
- MTZMasTec
Datasets
Frequently Asked Questions
How much of UNCY is sold short?
What is UNCY's daily short volume?
Does UNCY have fails to deliver?
Are UNCY insiders buying or selling?
Have UNCY insiders filed to sell?
Who owns 5% or more of UNCY?
Which tracked 13F managers own UNCY?
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.